MeSH tree: C19.246.300
A new analysis presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) examined daily oral orforglipron treatment for the treatment of obesity, with or without diabetes, in users aged 65 years ...
May 10, 2026
0
4
Until now, research into type 2 diabetes has focused primarily on insulin: if the body's cells become less responsive to the hormone produced in the pancreas, blood glucose levels rise over the long term. A recent study by ...
May 10, 2026
0
7
New research led by the Health Policy Center at the South Australian Health and Medical Research Institute (SAHMRI) has shown that placing sugar warning labels on sugary drinks would significantly change adolescents' behavior—leading ...
May 8, 2026
0
6
For decades, physicians and scientists thought metformin, the leading type 2 diabetes medication taken by millions worldwide, mainly targets the liver to suppress glucose production. But a new Northwestern University study ...
May 8, 2026
0
172
Changes in gut microbiota after bariatric surgery are strongly linked to altered metabolic health and sustained improvement in type 2 diabetes, according to a study led by researchers at the University of Gothenburg.
May 7, 2026
0
4
A hallmark of type 2 diabetes is the progressive loss of beta cell mass: cells in the pancreas that produce and release insulin. The endoplasmic reticulum stress response, a cellular pathway that maintains protein homeostasis, ...
May 7, 2026
0
4
People who eat more ultra-processed food (UPF) have a higher risk of cardiovascular disease and death, according to a report published in the European Heart Journal. The report, by a group of cardiology experts from across ...
May 6, 2026
0
7
Some clinical trials aren't designed to answer scientific questions. They're designed to market drugs. In our recently published research, my team and I analyzed over 34,000 industry-funded trials and found that hundreds ...
May 6, 2026
0
4
New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people with metabolic disease often face poorer cancer outcomes and pointing to future ways to predict recurrence ...
May 6, 2026
0
4
Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and ...
May 6, 2026
0
6
